San Francisco, 18 December 2018, Biochip Market Analysis By Type, (DNA
Chips, Lab-On-a-Chip, Protein Chips, Cancer Diagnosis And Treatment, Gene
Expression, Single Nucleotide Polymorphism (SNP) Genotyping, Genomics, Drug
Discovery, Agricultural Biotechnology, Proteomics, Expression Profiling, High
Throughput Screening), By End Use (Biotechnology & Pharmaceutical
Companies, Hospitals & Diagnostics Centers, Academic & Research
Institutes), And Segment Forecasts To 2024
Global biochip market to reach USD 25.84 billion by 2024, according to a
new report by Grand View Research, Inc. Growing adoption of personalized
medicine and rapid technological advancements in the biochips market along with
high market demand from proteomic and genomic applications is expected to drive
market growth.
Anticipated launch and
commercialization of novel products for diagnosis and treatment including
laboratory- and non-laboratory-based research are expected to further reinforce
growth in demand. Improvements in accuracy, resolution, and preparation
procedures for the technology coupled with reduction in costs of associated
materials are expected to fuel growth over the forecast period.
Ongoing developments related to
further miniaturization of biochips are expected to enhance their applicability
and additional usage for genetic sequencing methodologies, such as cancer
genomics. Their usage is also expected to aid reduction in the cost of genome
profiling, which is a factor likely to drive demand for the next step of
genetic analysis, i.e., protein expression analysis. Consequently, a growth in
the number of such protein profiling studies is expected to directly fuel
demand for genomic and proteomic labeling techniques through to 2024.
Access Full Research Report On Biochip Market Analysis: www.grandviewresearch.com/industry-analysis/biochips-market
Further Key Findings From the Report Suggest:
·
DNA chips form the largest
revenue-generating segment of the biochip applications. Major contribution to
this share comes from usage in cancer diagnostics/treatment and drug discovery
applications. DNA chips accounted for around a third of the global market
revenue in 2015. The other notable contributing segments to application of
biochips include gene expression, single nucleotide polymorphism genotyping,
genomic studies, and agricultural biotechnology.
·
The market is expected to have
a high potential for growth as the technology has numerous applications to aid
the miniaturization of molecular biology and biochemical & chemical assays.
Over time, such miniaturization is expected to benefit medical technologies in
terms of cost and input requirements.
·
DNA chips, lab-on-a-chip,
protein chips, and tissue & cell arrays find a number of uses in
pharmaceutical & biotechnology companies, academic & research
institutes, hospitals & diagnostic centers, and other end users like
point-of-care settings, forensic labs, blood banks, etc.
·
North America was the largest
revenue-generating region and accounted for over 45%of total revenue in 2015.
This can be attributed to by the presence of government initiatives for
personalized patient care coupled with the availability of a very large
installed base of genetic and proteomic profiling platforms across the U.S.
High market usage of next-gen sequencing techniques for molecular diagnosis and
treatment used with microfluidic techniques also add to the large share.
Furthermore, cancer analysis projects in a number of academic and clinical
research institutes are also responsible for the region’s large share.
·
Some key players operating in
this industry include Abbott Laboratories; PerkinElmer, Inc.; GE Healthcare;
Illumina, Inc.; Thermo Fisher Scientific, Inc.; Merck Millipore; Agilent
Technologies, Inc.; Sigma-Aldrich Corporation; Fluidigm Corporation; and
Bio-Rad Laboratories, Inc.
Browse More Reports Of This Category By
Grand View Research At: www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the
Biochip market on the basis of type, end use, region:
Biochip Outlook, by Type
(Revenue, USD Million, 2013 - 2024)
·
DNA chips, by application
o
Cancer diagnosis and treatment
o
Gene expression
o
Single Nucleotide Polymorphisms
Genotyping
o
Genomics.
o
Drug discovery
o
Agricultural biotechnology
o
Others
·
Lab-on-a-chip, by application
o
Genomics
o
IVD & POC
o
Proteomics
o
Drug discovery
o
Others
·
Protein chips, by application
o
Proteomics
o
Expression Profiling
o
Diagnostics
o
HTS
o
Drug Discovery
o
Others
·
Tissue Arrays
·
Cell Arrays
Biochip Outlook, by End Use
(Revenue, USD Million, 2013 - 2024)
·
Biotechnology and
Pharmaceutical Companies
·
Hospitals and Diagnostics
Centers
·
Academic & Research
Institutes
·
Others
Biochip Regional Outlook
(Revenue, USD Million, 2013 - 2024)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
UK
·
Asia Pacific
o
China
o
Japan
·
Latin America
o
Brazil
·
MEA
o
South Africa
Access Full Press Release of this Report:
www.grandviewresearch.com/press-release/global-biochip-market
www.grandviewresearch.com/press-release/global-biochip-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and
consulting company, registered in the State of California and headquartered in
San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
For more information: www.grandviewresearch.com/
